| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |